BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32221079)

  • 1. Nomograms predict survival outcomes for distant metastatic pancreatic neuroendocrine tumor: A population based STROBE compliant study.
    Li G; Tian ML; Bing YT; Wang HY; Yuan CH; Xiu DR
    Medicine (Baltimore); 2020 Mar; 99(13):e19593. PubMed ID: 32221079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database.
    Huang R; Sun Z; Zheng H; Yan P; Hu P; Yin H; Zhang J; Meng T; Huang Z
    Orthop Surg; 2019 Oct; 11(5):801-810. PubMed ID: 31663279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of Prognostic Nomograms for Patients with Duodenal Neuroendocrine Neoplasms.
    Sun S; Wang W; He C
    Med Sci Monit; 2020 Jun; 26():e922613. PubMed ID: 32564052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis.
    Yang L; Yu J; Zhang S; Shan Y; Li Y; Xu L; Zhang J; Zhang J
    J Ovarian Res; 2022 Feb; 15(1):26. PubMed ID: 35168642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological features and prognosis factors for survival in elderly patients with pancreatic neuroendocrine tumor: A STROBE-compliant article.
    Li G; Tian ML; Bing YT; Tao LY; Wang HY; Jiang B; Yuan CH; Xiu DR
    Medicine (Baltimore); 2019 Mar; 98(11):e14576. PubMed ID: 30882623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic models for predicting overall and cancer-specific survival of patients with initially diagnosed metastatic cervical squamous cell carcinoma: A study based on SEER database.
    Ding R; Su Z; Chen M; Chen L
    Medicine (Baltimore); 2023 Jul; 102(28):e34313. PubMed ID: 37443499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomograms and risk classification systems predicting overall and cancer-specific survival in primary malignant cardiac tumor.
    Guan T; Li Y; Qiu Z; Zhang Y; Lin W; Lai Y; Wang K; Shen Y; Du L; Liu C
    J Card Surg; 2019 Dec; 34(12):1540-1549. PubMed ID: 31794125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a nomogram for predicting survival in patients with gastrointestinal stromal tumours.
    Song W; Lv CG; Miao DL; Zhu ZG; Wu Q; Wang YG; Chen L
    Eur J Surg Oncol; 2018 Oct; 44(10):1657-1665. PubMed ID: 30082175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and Verification of Prognostic Nomograms for Patients with Gastrointestinal Stromal Tumors: A SEER-Based Study.
    Chen Z; Lin RM; Bai YK; Zhang Y
    Biomed Res Int; 2019; 2019():8293261. PubMed ID: 31032364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prognostic nomogram in patients with distant metastasis of pancreatic neuroendocrine tumors: a population-based study.
    Cai JS; Chen HY; Lu YF; Yu RS
    Future Oncol; 2020 Jan; 16(2):4369-4379. PubMed ID: 31802701
    [No Abstract]   [Full Text] [Related]  

  • 11. Development and validation of novel nomograms for predicting the survival of patients after surgical resection of pancreatic ductal adenocarcinoma.
    Li G; Chen JZ; Chen S; Lin SZ; Pan W; Meng ZW; Cai XR; Chen YL
    Cancer Med; 2020 May; 9(10):3353-3370. PubMed ID: 32181599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.
    Shi X; Xu L; Ma B; Wang S
    Sci Rep; 2020 Aug; 10(1):14143. PubMed ID: 32839498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and survival trends for gastric neuroendocrine neoplasms: An analysis of 3523 patients in the SEER database.
    Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
    Eur J Surg Oncol; 2018 Oct; 44(10):1628-1633. PubMed ID: 29983275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.
    Feng Y; Wang Y; Xie Y; Wu S; Li Y; Li M
    BMC Cancer; 2021 Apr; 21(1):450. PubMed ID: 33892663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two Novel Nomograms Predicting the Risk and Prognosis of Pancreatic Cancer Patients With Lung Metastases: A Population-Based Study.
    Zhang W; Ji L; Zhong X; Zhu S; Zhang Y; Ge M; Kang Y; Bi Q
    Front Public Health; 2022; 10():884349. PubMed ID: 35712294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors, survival analysis, and nomograms for distant metastasis in patients with primary pulmonary large cell neuroendocrine carcinoma: A population-based study.
    Song Z; Zou L
    Front Endocrinol (Lausanne); 2022; 13():973091. PubMed ID: 36329892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Nomograms for Primary High-Grade Glioma Patients in Adult: A Retrospective Study Based on the SEER Database.
    Yang Y; Yao M; Long S; Xu C; Li L; Li Y; Li G
    Biomed Res Int; 2020; 2020():1346340. PubMed ID: 32775408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomograms for primary mucinous ovarian cancer: A SEER population-based study.
    Qi X; Xu L; Wang J; Yu J; Wang Y
    J Gynecol Obstet Hum Reprod; 2022 Sep; 51(7):102424. PubMed ID: 35697250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic nomogram predicts overall survival in pulmonary large cell neuroendocrine carcinoma.
    He Y; Liu H; Wang S; Chen Y
    PLoS One; 2019; 14(9):e0223275. PubMed ID: 31560723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of Nomograms Predicting Overall and Cancer-Specific Survival of Spinal Chondrosarcoma Patients.
    Song K; Song J; Shi X; Wang H; Ma X; Xia X; Liang X; Lin K; Jiang J
    Spine (Phila Pa 1976); 2018 Nov; 43(21):E1281-E1289. PubMed ID: 29664813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.